There could soon be a new vaccine available – and it works in a completely different way than the others currently being used.
The US pharmaceutical company Novavax has put forward its Covid jab, Nuvaxovid for approval by Swissmedic.
The new drug will be the first protein vaccine available in the country. It contains a coronavirus spike protein which triggers the immune system.
In trials in the US and the UK, results suggest it provides a protection level of around 90%.
It does have another major advantage. It can be kept in a fridge for six months which makes distribution much easier.
Switzerland could be doing more for the environment
Most don't want further cuts to international aid
Teen killed on train tracks in Vaud
Several illnesses around at the moment
FC Stade Nyonnais could be rejected from Challenge League
Dog owners call for lakeside swimming area
